Treatment of Lambert-Eaton Syndrome With 3,4 DAP
Expanded access is currently available for this treatment.
Verified November 2012 by University of California, Davis
Sponsor:
University of California, Davis
Collaborator:
Jacobus Pharmaceutical
Information provided by (Responsible Party):
David P. Richman, MD, University of California, Davis
ClinicalTrials.gov Identifier:
NCT00704925
First received: June 23, 2008
Last updated: November 7, 2012
Last verified: November 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | Expanded access is currently available for this treatment. |
|---|---|
| Estimated Study Completion Date: | June 2011 |
| Estimated Primary Completion Date: | June 2010 (Final data collection date for primary outcome measure) |